BCL-XL deficiency, caused by either treatment with DT2216 or genetic knockout (KO), influenced neither apoptosis nor colony-forming efficiency of cancer cells in vitro (Supplementary Fig. 5g–i). The gene discussed is BCL2L1; the disease is cancer.